{ "items" : [
    { "id" : "http://dbpedia.org/resource/Mark_Millan"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Mark J. Millan is a neuroscientist specialising in the study and improved treatment of disorders of brain. He is currently the Director of Pharmacological Innovation for the Central Nervous System (CNS) at the Institute de Recherché de Servier (IDRS) in Paris, France. He is also the Secretary of the European College of Neuropsychopharmacology." ] ,
        "http://xmlns.com/foaf/0.1/name" : [ "Mark J. Millan",
          "Millan, Mark" ] ,
        "http://dbpedia.org/ontology/almaMater" : [ "http://dbpedia.org/resource/University_of_Cambridge" ] ,
        "http://dbpedia.org/ontology/birthDate" : [ "1956-10-24Z" ] ,
        "http://dbpedia.org/ontology/birthPlace" : [ "http://dbpedia.org/resource/Edinburgh",
          "http://dbpedia.org/resource/Scotland" ] ,
        "http://dbpedia.org/ontology/birthYear" : [ "1956Z" ] ,
        "http://dbpedia.org/ontology/field" : [ "http://dbpedia.org/resource/Neuroscience",
          "http://dbpedia.org/resource/Psychopharmacology" ] ,
        "http://dbpedia.org/ontology/knownFor" : [ "http://dbpedia.org/resource/Schizophrenia",
          "http://dbpedia.org/resource/Depression_(mood)",
          "http://dbpedia.org/resource/Pain" ] ,
        "http://dbpedia.org/ontology/residence" : [ "http://dbpedia.org/resource/France"] } } }
